Inactive Instrument

Longevity Acquisition Corporation

Equities

LOAC

VGG563721320

Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2018

January 11, 2019 at 09:12 pm

Longevity Acquisition Corporation announced earnings results for the third quarter ended November 30, 2018. For the third quarter, the company announced operating loss was USD 216,669 compared to USD 216,669 a year ago. Net loss was USD 15,557 compared to USD 15,557 a year ago. Basic loss per share was USD 0.11 compared to USD 0.11 a year ago. For the nine months, operating loss was USD 223,617 compared to USD 223,617 a year ago. Net loss was USD 22,505 compared to USD 22,505 a year ago. Basic loss per share was USD 0.14 compared to USD 0.14 a year ago.

Latest news about Longevity Acquisition Corporation

4D Pharma : Lists on Nasdaq As Longevity Merger Closes, Raises $25 Million Via Share Placement	22/03/21	MT
4D pharma plc completed the acquisition of Longevity Acquisition Corporation from Whale Management Corporation and others.	21/03/21	CI
Longevity Acquisition Corporation(NasdaqCM:LOAC) dropped from NASDAQ Composite Index	19/03/21	CI
Longevity Acquisition : Shareholders Approve Merger With 4D Pharma	18/03/21	MT
4D Pharma : ADS Listing on Nasdaq Approved by US SEC	26/02/21	MT
Longevity Acquisition Corporation Announces 4D Pharma plc Update on Oncology Program	03/02/21	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2020	13/01/21	CI
Longevity Acquisition : Regains Compliance With Nasdaq Listing Rules	11/12/20	MT
Longevity Acquisition : 4D Pharma Files for SEC Registration, in Process to Gain NASDAQ Listing	27/11/20	MT
Longevity Acquisition : Extends Proposed Deal Completion to May	20/11/20	MT
Longevity Acquisition Corporation Announces Management Changes	22/10/20	CI
Longevity Acquisition Corporation Announces Executive Changes	22/10/20	CI
Longevity Acquisition Corporation Announces Board Changes	22/10/20	CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2020	07/10/20	CI
4D pharma plc signed a non-binding letter of intent to acquire Longevity Acquisition Corporation from Whale Management Corporation and others for $50.4 million.	06/10/20	CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2020	09/07/20	CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 29, 2020	30/04/20	CI
Longevity Acquisition Corporation announced that it has received $0.4 million in funding from Whale Management Corporation	20/02/20	CI
Longevity Acquisition Corporation Announces Board Changes	24/01/20	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2019	10/01/20	CI
Longevity Acquisition Corporation Announces Board Changes	05/12/19	CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2019	16/10/19	CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2019	15/07/19	CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 28, 2019	29/05/19	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2018	11/01/19	CI

Chart Longevity Acquisition Corporation

Duration

Period

More charts

Company Profile

Longevity Acquisition Corporation is a China-based blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation. The Company purchases all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities.

Sector

More about the company